Evelo Biosciences, Inc.

CIK 1694665 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Evelo Biosciences, Inc..

Recent SEC filings

FiledFormAccession number
Mar 8, 2024EFFECT9999999995-24-000624
Jan 26, 20248-K0001193125-24-016885
Jan 26, 2024POS AM0001193125-24-016886
Jan 26, 202415-12G0001193125-24-016898
Jan 26, 2024S-8 POS0001193125-24-016894
Jan 26, 2024S-8 POS0001193125-24-016892
Dec 27, 202325-NSE0001354457-23-000999
Dec 12, 2023DEFA14A0001140361-23-057274
Dec 12, 2023DEF 14A0001140361-23-057273
Dec 11, 2023SC 13G/A0000315066-23-002794
Dec 4, 20238-K0001193125-23-287901
Dec 1, 2023PRE 14A0001140361-23-055595
Nov 21, 20238-K0001694665-23-000186
Nov 13, 2023SC 13G/A0000315066-23-002746
Nov 9, 202310-Q0001694665-23-000182
Nov 8, 202340001694665-23-000178
Nov 8, 202340001694665-23-000179
Nov 8, 202340001694665-23-000175
Nov 8, 202340001694665-23-000176
Nov 3, 202340001694665-23-000169
Nov 3, 202340001694665-23-000167
Nov 3, 202340001694665-23-000168
Oct 27, 20238-K0001193125-23-265281
Oct 17, 20238-K0001694665-23-000163
Sep 29, 202340001694665-23-000160